Fundraising Fox

DeepCyte

Wilmington, US · Founded 2025 · Delaware corporation

Founders & leadership

TA
THEODORE ALEXANDROVNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 1 round · 2026

▶$1.4MraisedJan 2026 · 10 investors · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • THEODORE ALEXANDROVExecutive Officer
Offering amount
$1.7M
Amount sold
$1.4M
Minimum investment
$100K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

DeepCyte: $1.5 Million Seed Funding Launches AI-Powered Single-Cell Toxicology Platformpulse2.com · Apr 2026DeepCyte Raises $1.5M in Seed Fundingfinsmes.com · Apr 2026DeepCyte Raises $1.5M to Build AI Tools That Detect Drug Toxicity Before Clinical Trialsjustainews.com · Apr 2026DeepCyte Raises $1.5M funding to Advance AI Drug Toxicologyworldpharmatoday.com · Apr 2026DeepCyte Launches With $1.5M Seed to Apply Single-Cell AI to Drug Toxicity Risk - TipRanks.comtipranks.com · Apr 2026Single-Cell Drug Toxicity Prediction Startup DeepCyte Launches With $1.5M in Seed Funding | GenomeWebgenomeweb.com · Apr 2026

Frequently asked questions

How much funding has DeepCyte raised?
DeepCyte has disclosed $1.4M raised across 1 round.
Where is DeepCyte headquartered?
DeepCyte is headquartered in Wilmington, US.